Surgical management of papillary thyroid carcinoma: an overview

被引:0
作者
Paolo Miccoli
Sohail Bakkar
机构
[1] University of Pisa,Division of Endocrine Surgery, Department of Surgical, Medical, Molecular Pathology and Critical Area
[2] The Hashemite University,Department of Surgery, Faculty of Medicine
来源
Updates in Surgery | 2017年 / 69卷
关键词
Papillary thyroid carcinoma; Surgical management; Thyroid lobectomy; Total thyroidectomy;
D O I
暂无
中图分类号
学科分类号
摘要
The surgical management of papillary thyroid carcinoma remains contentious and the optimal surgical strategy has not been yet established. The extent of thyroid resection has been the nub of this debate. Literature lacks prospective randomized controlled trials that could help put this debate to rest, and these have been labeled as being impractical. Consequently, large retrospective studies and expert opinion have constituted the basis of clinical practice guidelines. Recent American Thyroid Association and National Comprehensive Cancer Network guidelines consider a conservative approach in the form of a thyroid lobectomy sufficient for low-risk disease and that total thyroidectomy remains the standard of care in the presence of high-risk features. Nevertheless, many authorities still advocate more aggressive therapy for low-risk disease. The challenge in standardizing the surgical strategy to papillary thyroid carcinoma is mainly related to a major tumor characteristic: the high frequency of occult cancerous foci whether within the thyroid gland itself or within loco-regional lymph nodes as this tumor characteristic has been incriminated for a higher risk of recurrent disease and its adverse sequelae. The purpose of this article is to provide an overview of the surgical management of papillary thyroid carcinoma and the main arguments surrounding this hotly debated topic. All evidences for this review article were drawn from PubMed articles in English language mostly cross-referenced with international guideline statements.
引用
收藏
页码:145 / 150
页数:5
相关论文
共 380 条
[1]  
Morris L(2010)Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis Am J Surg 200 454-461
[2]  
Myssiorek D(2014)Current thyroid cancer trends in the United States JAMA Otolaryngol Head Neck Surg 140 317-322
[3]  
Davies L(2015)Thyroid cancer mortality and incidence: a global overview Int J Cancer 136 2187-2195
[4]  
Welch HG(1996)Optimal surgery for papillary thyroid carcinoma World J Surg 20 88-93
[5]  
La Vecchia C(2000)Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy Endocr Pract 6 469-476
[6]  
Malvezzi M(2016)2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer Thyroid 26 1-133
[7]  
Bosetti C(2014)Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients Ann Surg 260 601-615
[8]  
Garavello W(2007)Extent of surgery affects survival for papillary thyroid cancer Ann Surg 246 375-381
[9]  
Bertuccio P(2009)Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 1167-1214
[10]  
Levi F(2015)Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years J Clin Endocrinol Metab 100 115-121